发明申请
US20060030526A1 Stable suspension formulations of erythropoietin receptor agonists 有权
稳定的促红细胞生成素受体激动剂的悬浮液制剂

Stable suspension formulations of erythropoietin receptor agonists
摘要:
A suspension formulation for therapeutic use includes a non-aqueous, single-phase vehicle exhibiting viscous fluid characteristics and a particle formulation comprising an erythropoietin receptor agonist dispersed in the vehicle.
信息查询
0/0